XML 15 R8.htm IDEA: XBRL DOCUMENT v3.24.3
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 9 Months Ended
Nov. 02, 2024
Oct. 28, 2023
Operating activities:    
Net income $ 225,034,000 $ 163,722,000
Adjustments to reconcile net income to net cash from operating activities:    
Depreciation and amortization 163,524,000 174,559,000
Share-based compensation 33,372,000 35,289,000
Deferred income taxes (10,279,000) 15,691,000
Loss on impairment of assets 6,353,000 10,759,000
Changes in assets and liabilities:    
Accounts receivable 28,032,000 3,906,000
Merchandise inventory (185,521,000) (186,546,000)
Operating lease assets 166,605,000 201,810,000
Operating lease liabilities (194,353,000) (241,760,000)
Other assets (75,265,000) 793,000
Accounts payable 18,333,000 65,630,000
Accrued compensation and payroll taxes (61,317,000) 44,584,000
Accrued and other liabilities (21,473,000) (4,094,000)
Net cash provided by operating activities 93,045,000 284,343,000
Investing activities:    
Capital expenditures for property and equipment (157,668,000) (134,915,000)
Sale of available-for-sale investments 100,000,000  
Other investing activities (8,385,000) (9,346,000)
Net cash (used for) investing activities (66,053,000) (144,261,000)
Financing activities:    
Repurchase of common stock as part of publicly announced programs (130,941,000)  
Repurchase of common stock from employees (13,645,000) (10,666,000)
Proceeds from revolving line of credit   30,000,000
Principal payments on revolving line of credit   (30,000,000)
Net proceeds from stock options exercised 3,841,000 1,561,000
Cash dividends paid (72,628,000) (59,121,000)
Other financing activities (4,635,000) (762,000)
Net cash (used for) financing activities (218,008,000) (68,988,000)
Effect of exchange rates changes on cash (2,883,000) (363,000)
Net change in cash and cash equivalents (193,899,000) 70,731,000
Cash and cash equivalents - beginning of period 354,094,000 170,209,000
Cash and cash equivalents - end of period $ 160,195,000 $ 240,940,000